26.79
0.71%
0.19
Handel nachbörslich:
26.79
Finanzdaten der Ideaya Biosciences Inc-Aktie (IDYA)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
100.00%
-
|
3.922 | 8.038 | 3.544 | 7.88 |
Operating Expenses
|
11.30%
51.02
|
45.84 | 41.56 | 36.25 | 34.16 |
Depreciation and Amortization |
14.29%
0.60
|
0.70 | 0.60 | 0.60 | 0.60 |
Operating Income/Loss |
21.71%
-51.02
|
-41.92 | -33.53 | -32.71 | -26.28 |
Nonoperating Income/Loss |
43.75%
11.45
|
7.962 | 6.086 | 4.783 | 2.639 |
Income/Loss From Continuing Operations Before Tax |
16.54%
-39.57
|
-33.95 | 8.038 | 3.544 | -23.64 |
Income Tax Expense/Benefit |
-
|
- | - | - | - |
Income/Loss From Continuing Operations After Tax |
16.54%
-39.57
|
-33.95 | -27.44 | -27.93 | -23.64 |
Net Income/Loss
|
16.54%
-39.57
|
-33.95 | -27.44 | -27.93 | -23.64 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
2,785%
75.11
|
2.6038 | 60.00 | 56.25 | 48.37 |
Diluted Average Shares |
2,785%
75.11
|
2.6038 | 60.00 | 56.25 | 48.37 |
Basic Earnings Per Share |
1.92%
-0.53
|
-0.52 | -0.46 | -0.50 | -0.49 |
Diluted Earnings Per Share |
1.92%
-0.53
|
-0.52 | -0.46 | -0.50 | -0.49 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):